Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001209191-23-014609

EVP, Chief Commercial Officer acquired 38,769 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ajer Jeffrey Robert EVP, Chief Commercial Officer 2023-02-28 Grant or award +20,760 61,848 D: show line 1 in the form
Ajer Jeffrey Robert EVP, Chief Commercial Officer 2023-02-28 Grant or award +10,380 72,228 D: show line 2 in the form
Ajer Jeffrey Robert EVP, Chief Commercial Officer 2023-02-28 Grant or award +7,629 79,857 D: show line 3 in the form
Loading xslF345X03/doc4.xml…